Title:
癌を治療するための毒素および放射性核種結合IGF-1受容体リガンド
Document Type and Number:
Japanese Patent JP2008517917
Kind Code:
A
Abstract:
The invention provides an insulin-like growth factor-1 (IGF-1) receptor ligand carrying a therapeutic radionuclide for treatment of cancer is provided. A method of treating cancer using the IGF-1 receptor ligand carrying a therapeutic radionuclide is also provided. An anti-cancer therapeutic agent containing an IGF-1 receptor ligand linked to a toxin is also provided, as are methods of using the toxin conjugates for treatment of cancer.
Inventors:
Mactabish, hugh
Application Number:
JP2007538030A
Publication Date:
May 29, 2008
Filing Date:
October 21, 2005
Export Citation:
Assignee:
IG F Oncology LLC
International Classes:
A61K51/00; A61K38/00; A61K45/00; A61K47/48; A61P35/00; A61P35/02; A61P43/00; G01N33/15; G01N33/50
Domestic Patent References:
| JP2004520808A | 2004-07-15 |
Foreign References:
| US20030092631A1 | 2003-05-15 | |||
| US4876242A | 1989-10-24 |
Other References:
JPN6011034051; Ｃａｎｃｅｒ Ｒｅｓｅａｒｃｈ， １９９１， Ｖｏｌ．５１， ｐｐ．１７４-１８０
Attorney, Agent or Firm:
Atsushi Nakajima
Kato Kazunori
Katsuichi Nishimoto
Kato Kazunori
Katsuichi Nishimoto